ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 27.69

Change

-0.32 (-1.14)%

Market Cap

N/A

Volume

4.61K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.27 (+0.85%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.27 (+0.97%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.13 (+0.53%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.17 (-0.50%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.02 (+0.04%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.10 (+0.35%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.02 (+0.18%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.99% 59% D- 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.99% 59% D- 56% F
Trailing 12 Months  
Capital Gain -4.52% 31% F 34% F
Dividend Return 3.86% 80% B- 70% C-
Total Return -0.66% 36% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.07% 41% F 40% F
Dividend Return 3.06% 43% F 36% F
Total Return 0.99% 82% B 38% F
Risk Return Profile  
Volatility (Standard Deviation) 4.54% 84% B 93% A
Risk Adjusted Return 67.51% 74% C 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.